The FDA has approved an expanded label for Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test, which identifies patients with HR–positive, HER2-ultralow metastatic breast ...

Patients might not know about Roche Tissue Diagnostics, but the Arizona entity has been testing for cancer and helping devise treatments for 40 years.

Lipoprotein(a) has long been recognized as a critical marker for people at risk of cardiovascular disease. However, the health care industry has lacked the tools to tackle the problem.

Roche and Eli Lilly have started testing a blood test that could be used to diagnose Alzheimer’s before symptoms arise, providing an alternative to expensive brain scans and speeding up the ...

The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for ...

Roche has obtained U.S. government green lights ... influenza B and strep throat, as well as an in-lab test for Clostridium difficile, or C. diff.

3 "Accurately differentiating lymphoma from an infection is critical in ensuring accurate and timely diagnosis, especially as the symptoms can appear similar," said Jill German, Head of Pathology Lab ...

1 The Roche Diagnostics Tina-quant® Lipoprotein (a) Gen.2 Molarity assay is an in-vitro test measuring lipoprotein (a) in a person's bloodstream (serum and plasma), and will be broadly available ...

Roche stopped studying cibisatamab in combination with its checkpoint inhibitor Tecentriq in colorectal cancer patients last year but continued to test the asset with its 4-1BBxFAP bispecific.

"The HPV test will be rolled out on February 4 to coincide with World Cancer Day," an official with Metropolis said ...

Roche Tissue Diagnostics also collaborates with dozens of pharmaceutical companies to test and develop better tools for evaluating cancer treatments. It doesn't engage in animal testing or conduct ...